These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2854693)

  • 1. Clinical evaluation of hemostatic molecular markers.
    Kazama M
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1387-94. PubMed ID: 2854693
    [No Abstract]   [Full Text] [Related]  

  • 2. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
    Nakajima H
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
    Walenga JM; Fareed J; Hoppensteadt D
    Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
    Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular markers of hemostatic activation in atherosclerosis: a new concept in diagnostic profiling of endogenous pathophysiologic transition.
    Fareed J; Walenga JM; Baker WH; Hayes A; Hoppensteadt DA
    Semin Thromb Hemost; 1986 Apr; 12(2):102-9. PubMed ID: 2943019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmatic markers of haemostatic system activation in patients with solid neoplasms.
    Sagripanti A; Carpi A; Ferdeghini M; Baicchi U; Grassi B
    J Nucl Med Allied Sci; 1990; 34(4):321-32. PubMed ID: 2151044
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma fibrinopeptide A and beta-thromboglobulin in major bacterial infections.
    van Hulsteijn H; Fibbe W; Bertina R; Briët E
    Thromb Haemost; 1982 Dec; 48(3):247-9. PubMed ID: 6187081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
    Roy MS; Podgor MJ; Rick ME
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of natural coagulation inhibitors in hemostasis.
    Brandt JT
    Clin Lab Med; 1984 Jun; 4(2):245-84. PubMed ID: 6094091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Etiologic evaluation of deep venous thrombosis: hemostasis tests to perform].
    Sie P
    Ann Biol Clin (Paris); 1985; 43(6):817-9. PubMed ID: 3841708
    [No Abstract]   [Full Text] [Related]  

  • 11. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
    Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
    J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of fibrinopeptide A and D-dimer in diagnostics of hemostasis disorders].
    Riabov GA; Pasechnik IN; Azizov IuM
    Anesteziol Reanimatol; 2003; (1):69-74. PubMed ID: 12696462
    [No Abstract]   [Full Text] [Related]  

  • 13. The overall hemostasis potential: a laboratory tool for the investigation of global hemostasis.
    Antovic A
    Semin Thromb Hemost; 2010 Oct; 36(7):772-9. PubMed ID: 20978998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation in vivo in man--effect of low-dose aspirin.
    Kyrle PA; Westwick J; Scully MF; Kakkar VV; Lewis GP
    Thromb Haemost; 1987 Feb; 57(1):62-6. PubMed ID: 2954260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The evaluation of hemostatic disorders in patients with systemic lupus erythematosus].
    Arshinov AV; Lapin VA; Raĭt IuA
    Ter Arkh; 1999; 71(5):38-40. PubMed ID: 10399229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulation of hemostasis: the protein C system.
    Clouse LH; Comp PC
    N Engl J Med; 1986 May; 314(20):1298-304. PubMed ID: 3010107
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired fibrinolytic response to increased thrombin activation in type 1 diabetes mellitus: effects of the glycosaminoglycan sulodexide.
    Ceriello A; Quatraro A; Marchi E; Barbanti M; Giugliano D
    Diabete Metab; 1993; 19(2):225-9. PubMed ID: 8339853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives and the hemostatic system.
    Farag AM; Bottoms SF; Mammen EF; Hosni MA; Ali AA; Moghissi KS
    Obstet Gynecol; 1988 Apr; 71(4):584-8. PubMed ID: 3353050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electrocoagulography using integral indices in assessing hemostatic disorders in children].
    Baranov AA
    Anesteziol Reanimatol; 1988; (6):59-61. PubMed ID: 3245625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.